XML 56 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2012
Successor [Member]
Mar. 19, 2012
Predecessor [Member]
Dec. 31, 2011
Predecessor [Member]
Dec. 31, 2010
Predecessor [Member]
Cash flows from operating activities:        
Net (loss) income $ (12,353) $ (3,433) $ (10,873) $ 5,412
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities before reorganization activities:        
Amortization of bond premium or discount 1,837 523 2,750 2,822
Net realized gain on sale of investments (2,747) (176) (1,206) (4,796)
Unrealized (gain) loss on trading securities 1,410 (1,049) 2,828 (396)
Equity-based compensation expense 143      
Changes in assets and liabilities:        
Accrued investment income 616 309 889 856
Other assets 1,588 (597) 1,385 162
Change in cash held in trust 9,230 7,209 3,998 (23,188)
Change in restricted cash (25,169)      
Losses and loss adjustment reserves (58,485) (1,109) (47,917) (66,390)
Losses payable (5,445) 1,662 (6,498) 9,784
Unearned premiums (184) (47) (222) (324)
Accrued ceding commission expense (330) 137 (259) 121
Accrued interest on notes payable 1,476      
Loss contract fair market value reserve (10,847)      
Other liabilities (3,514) 414 2,033 6,275
Total adjustments (90,421) 7,276 (42,219) (75,398)
Net cash provided by (used in) operating activities (102,774) 3,843 (53,092) (69,986)
Cash flows from investing activities:        
Purchase of investments (202,847) (38,506) (147,993) (224,791)
Proceeds from sales and maturities of investments 234,096 34,035 206,789 307,924
Net cash provided by (used in) investing activities 31,249 (4,471) 58,796 83,133
Cash flows from financing activities:        
Cash from (used in) reorganization activities:   75,000    
Notes payable-principal repayments (2,064)      
Notes payable-principal issued 8,336     (12,511)
Net cash provided by (used in) financing activities 6,272 75,000   (12,511)
Increase (decrease) in cash and cash equivalents (65,253) 74,372 5,704 636
Cash and cash equivalents, beginning of period 82,014 7,642 1,938 1,302
Cash and cash equivalents, end of period 16,761 82,014 7,642 1,938
Cash paid during the year:        
Interest 3,699      
Supplementary disclosure of non-cash investing and financing activities:        
Notes payable issued in lieu of cash interest payments $ 8,336